CDLX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
36.9M
+7.5%
34.3M
-38.8%
56.1M
+7.8%
52.0M
-10.4%
58.0M
Cost of Revenue
2.6M
+2.6%
2.6M
+103.5%
-72744000
-362.3%
27.7M
+417.8%
5.4M
Gross Profit
34.2M
+7.9%
31.7M
-75.4%
128.8M
+430.2%
24.3M
-53.9%
52.7M
Operating Expenses
39.7M
-0.8%
40.0M
-70.3%
134.9M
+45.3%
92.8M
+49.7%
62.0M
R&D
5.5M
-13.8%
6.4M
-19.3%
8.0M
-9.5%
8.8M
-10.8%
9.9M
SG&A
14.5M
-3.9%
15.0M
-12.8%
17.3M
-7.8%
18.7M
-11.6%
21.2M
Operating Income
-5441000
+34.2%
-8274000
-35.8%
-6095000
+91.1%
-68534000
-634.8%
-9327000
EBITDA
-1380000
+64.2%
-3856000
-674.7%
671.0K
+120.9%
-3218000
-5.4%
-3052000
Net Income
-14876000
-232.1%
-4480000
+45.7%
-8250000
+88.6%
-72673000
-682.9%
-9283000
EPS (Basic)
$-2.58
-222.5%
$-0.80
+1.2%
$-0.81
+94.0%
$-13.60
-672.7%
$-1.76
EPS (Diluted)
$-2.58
-222.5%
$-0.80
+1.2%
$-0.81
+94.0%
$-13.60
-672.7%
$-1.76
Shares (Diluted)
5.8M
+4.9%
5.5M
-46.1%
10.2M
+90.4%
5.3M
+1.4%
5.3M
Cardlytics (CDLX) โ€” Financials